864863-72-9
基本信息
6-[1-(2-fluoropyridin-3-yl)-5-methyltriazol-4-yl]quinoline
Quinoline, 6-[1-(2-fluoro-3-pyridinyl)-5-methyl-1H-1,2,3-triazol-4-yl]-
物理化学性质
| 储存条件 | -20°C储存 |
| 溶解度 | 溶于二甲基亚砜 |
| 形态 | Solid |
| 颜色 | Light yellow to yellow |
6-[1-(2-FLUOROPYRIDIN-3-YL)-5-METHYLTRIAZOL-4-YL]QUINOLINE价格(试剂级)
| 报价日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
| 2025/05/22 | HY-100382 | 6-[1-(2-FLUOROPYRIDIN-3-YL)-5-METHYLTRIAZOL-4-YL]QUINOLINE FPTQ | 864863-72-9 | 1 mg | 560元 |
| 2025/05/22 | HY-100382 | 6-[1-(2-FLUOROPYRIDIN-3-YL)-5-METHYLTRIAZOL-4-YL]QUINOLINE FPTQ | 864863-72-9 | 10mM * 1mLin DMSO | 940元 |
| 2025/05/22 | HY-100382 | 6-[1-(2-FLUOROPYRIDIN-3-YL)-5-METHYLTRIAZOL-4-YL]QUINOLINE FPTQ | 864863-72-9 | 5mg | 1400元 |
常见问题列表
|
Human mGluR1 6 nM (IC 50 ) |
Mouse mGluR1 1.4 nM (IC 50 ) |
FPTQ (0.5-10 μM) does not shows any cytotoxicity was not observed at 0.5, 1, 5, and 10 μM in RAW264.7 macrophage cells.FPTQ (1-20 μM; 24 hours) reduces LPS-induced NO production at > 1 μM FPTQ, and at 10 μM, FPTQ treatment causes a 31% anti-oxidant effect in RAW264.7 macrophage cells.FPTQ (1-20 μM; 24 hours) dramaticly decreases LPS-induced expression levels of IL-1β and Il-6. At a concentration of 10 μM, FPTQ causes a 27% and 44% reduction in the mRNA expression of IL-1β and Il-6, respectively in RAW264.7 macrophage cells.
RT-PCR
| Cell Line: | RAW264.7 macrophage cells |
| Concentration: | 1, 10, or 20 μM |
| Incubation Time: | 24 hours |
| Result: | Decreased IL-1β and IL-6 mRNA expression |
FPTQ (5-20 μM) decreases the number of neutrophils migrating to the amputation site in zebrafish larvae by tail amputation. In the tailfin wound method, the number of neutrophils collecting at the wound site also decreases in a dose-dependent manner in zebrafish.In a LPS-induced inflammation zebrafish model, LPS solution is injected into the yolks of Tg(mpx:EGFP) i114 zebrafish larvae and exposed the zebrafish larvae immediately to FPTQ treatment.FPTQ (20 μM; 4 hours) significantly decreases the fluorescent neutrophils after yolk injection and has an anti-inflammatory effect during the early phase of inflammation.